At the 2025 International Conference on Collaboration and Integration of Industry, Education, Research and Application (Chongqing) Symposium on Biomedical Sciences, Prof. Gautam Sethi, esteemed member of the Editorial Board of GPD Journal and a renowned international expert in oncology, delivered a compelling keynote lecture titled:“Pharmacological Strategies to Target Oncogenic Transcription Factors and c-Met/HGF Signaling in Cancer Therapy.”

Prof. Sethi’s presentation highlighted cutting-edge pharmacological approaches aimed at disrupting oncogenic transcription factors and the c-Met/HGF signaling axis—two pivotal drivers in cancer progression. His talk underscored promising therapeutic avenues with significant translational potential, drawing strong interest from young researchers and clinicians in attendance.

Beyond sharing his latest scientific insights, Prof. Sethi took the opportunity to introduce GPD Journal to the forum’s participants. He outlined GPD’s mission to advance high-impact, interdisciplinary research at the intersection of genomics, disease mechanisms, and precision medicine. Emphasizing the journal’s rapid growth and rigorous peer-review standards, he encouraged early-career scientists to submit their high-quality original work to GPD and contribute to global scholarly dialogue in gene-disease research.

Launched with a commitment to innovation and clinical relevance, GPD publishes groundbreaking studies across oncology, genetic disorders, metabolic diseases, neuroscience, and related fields. The journal is now indexed in multiple authoritative databases, including CAS (Chemical Abstracts Service) and ASCI (Asian Science Citation Index), reflecting its rising academic profile and international visibility.

GPD remains dedicated to serving as a dynamic platform for researchers worldwide to disseminate transformative science and foster collaboration across borders.